The tweet was deleted by the author.
But we saved everything 🙂.
Anika Therapeutics has announced that Cingal is the only approved combination of hyaluronic acid and corticosteroid for osteoarthritis pain management.
The product is positioned as fast-acting, long-lasting, and delivering consistent results, backed by clinical evidence. However, Cingal is not currently available in the U.S., according to the company.
Anika Therapeutics recently launched Hyaff, a proprietary hyaluronic acid derivative developed for regenerative tendon and cartilage repair. The company has also marked its commitment to research by celebrating Clinical Trials Day and advancing patient outcomes. Anika continues to focus on clinical innovation in the musculoskeletal health sector.